Revitalising life sciences hiring: The case for creative rec...
The labour market in the life sciences sector has stabilised, but employers are still finding it challenging to attract the best talent.
Newsletters and Deep Dive digital magazine
The labour market in the life sciences sector has stabilised, but employers are still finding it challenging to attract the best talent.
To encourage the uptake of complex therapies in clinical practice, brand teams must ensure they use data-driven insights to understand the needs and preferences of healthcare professionals
Damage to a Baxter manufacturing facility caused by Hurricane Helene, which rolled across the east US a couple of weeks ago, has led to shortages in some critical medicines.
The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide.
Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia, becoming the pharma group’s second new therapy for the blood disorder this year.
Editor's Picks
Newsletters and Deep Dive
digital magazine